Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
159 Patents
#10 in South San Francisco, CA
#543 in California
#2,496 in US
#5,178 in the World
Fluidigm Corporation
Forward Citations = 5,980
119 inventors:
South San Francisco, CA, United States of America
Fluidigm Corporation
% Expired Patents = 45.9
CIPO Patents = 3
EPO Patents = 24
Forward Citations = 5,980
Loading Chart...
Loading Chart...
119 inventors (with patents filed for the assignee):
Marc Alexander Unger (64 out of 103 patents)
Geoffrey Richard Facer (26 out of 26 patents)
Andrew Paul May (24 out of 71 patents)
4. Brian Fowler (21 out of 25 patents)
5. Hou-Pu Chou (20 out of 68 patents)
6. Michael Ybarra Lucero (18 out of 34 patents)
7. Gang Sun (15 out of 18 patents)
8. Hany Ramez Nassef (14 out of 15 patents)
9. Jing Wang (13 out of 13 patents)
10. Martin Pieprzyk (13 out of 13 patents)
11. Peilin Chen (12 out of 13 patents)
12. Christopher G Cesar (12 out of 14 patents)
13. Robert C Jones (12 out of 12 patents)
14. Ian D Manger (12 out of 12 patents)
15. Jason A A West (11 out of 15 patents)
Core Competencies:
Nucleic Acid Amplification
Single-Cell Analysis
Mass Spectrometry
Microfluidic Devices
Thermal Cycling
Optical Lens Systems
Multiplex Amplification
Biochip Fabrication
Particle Analysis
Digital PCR
Nucleic Acid Detection
Fluidic Systems
159 patents:
5. 11078476 - Methods and kits for extracting nucleic acids from paraffin embedded samples (2021-08-03),
11. 10344318 - Multi-primer amplification method for barcoding of target nucleic acids (2019-07-09),
Company Overview
Fluidigm Corporation, based in South San Francisco, specializes in microfluidic technologies that enable advanced biological research and diagnostics. The company focuses on developing innovative solutions for nucleic acid amplification, single-cell analysis, and mass spectrometry, leveraging its expertise in microfluidic devices and thermal cycling. Fluidigm's technologies are instrumental in applications such as multiplex amplification and biochip fabrication, facilitating breakthroughs in genomics and personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fluidigm Corporation. Retrieved from https://idiyas.com/company/fluidigm
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
24 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]